Cochlear Implantation in Sporadic Vestibular Schwannoma and Neurofibromatosis Type II

Otolaryngol Clin North Am. 2023 Jun;56(3):587-598. doi: 10.1016/j.otc.2023.02.017. Epub 2023 Apr 3.

Abstract

Cochlear implantation offers significantly better hearing outcomes than auditory brainstem implantation in patients with vestibular schwannoma. Neither the primary treatment modality nor the cause of the tumor (neurofibromatosis type 2 related or sporadic) seems to have a significant effect on hearing outcome with cochlear implantation. Some uncertainty remains regarding long-term hearing outcomes; however, cochlear implantation in vestibular schwannoma serves to offer patients, with a functioning cochlear nerve, the probability of open set speech discrimination with a consequent positive impact on quality of life.

Keywords: Cochlear implantation; Hearing rehabilitation; Neurofibromatosis type 2; Vestibular schwannoma.

Publication types

  • Review

MeSH terms

  • Cochlear Implantation*
  • Hearing / physiology
  • Humans
  • Neurofibromatosis 2* / complications
  • Neurofibromatosis 2* / surgery
  • Neuroma, Acoustic* / complications
  • Neuroma, Acoustic* / surgery
  • Quality of Life
  • Retrospective Studies
  • Treatment Outcome